Above data demonstrated that the anti-tumor effects of OMT on human osteosarcoma cell lines is at least partly due to its potential in up-regulating the nucleus PTEN expression and inhibiting PI3K/Akt signaling cascades. The gene discussed is AKT1; the disease is neoplasm.